tetravalent vaccine (University of Rochester)

N/A

Report date: 2025/03/19 11:41:11

Base Information

Drug Nametetravalent vaccine (University of Rochester)
Drug Alias Namedengue envelope protein plus HPV virus like particles (Codevax/University of Rochester Medical Center)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCodevax Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Rochester
Inactive CompaniesCodevax IncUniversity of Rochester Medical Center
Active IndicationsDengue
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A